Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
Recruiting now · Not applicable
Conditions studied: Deprescriptions, Antidepressive Agents, Antipsychotic Agents, Analgesics, Opioid, Hypnotics and Sedatives, Cholinergic Antagonists
In brief
The PARTNER study is a multicentre, two-arm, pragmatic cluster-randomised trial evaluating the impact of a focused and patient-centred cooperation between general practitioners (GPs) and community pharmacists (PARTNER intervention) on reductions in the use of psychotropic, sedative and anticholinergic potentially inappropriate medication (PSA-PIM) compared to a control intervention. The PARTNER intervention comprises (1) education for health care professionals, (2) an interprofessional workshop and case conference, (3) a pharmacy visit with brown bag/medication review and patient empowerment, (4) GP practice visit with shared decision making. The control intervention only comprises a pharmacy visit with brown bag review.
Key facts
- Study ID
- NCT05842928
- Run by
- Ludwig-Maximilians - University of Munich
- People needed
- 352
- Starts
- 2023-03-25
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2025-05-04
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged 65 years or older
- Patient is capable of giving consent
- GP contact in the quarter prior to inclusion
- Current use of ≥ 5 drugs, including ≥ 1 PSA-PIM (hypnotics, opioids, gabapentinoids, antipsychotics, antidepressants, anticholinergic urospasmolytics) with a treatment duration of ≥ 6 months
- Willingness to select a regular pharmacy for the study period
- Consent to data exchange between GP and community pharmacy
You may not qualify if…
- Terminal illness (life expectancy < 6 months)
- Current treatment of pain associated with cancer
- Other serious physical illness or mental distress (e.g. bereavement) that makes participation in the study impossible (according to the GP's assessment)
- Psychiatric illness or addiction that makes participation in the study impossible (according to the GP's assessment)
- Unable to meet the requirements of the study (participation in telephone or written questionnaires, visits to the GP practice or community pharmacy, alone or with the help of caregivers for physical infirmity)
- Current participation in research projects on medication safety or geriatric medicine
Where it is running
- University Hospital, LMU Munich — Munich, Germany (enrolling)
- University of Bielefeld — Bielefeld, Germany
- Witten/Herdecke University — Witten, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.